Is there a link between cervical dysplasia and HPV?

John Han-Chih Chang, MD and Kenneth Blank, MD
Ultima Vez Modificado: 1 de noviembre del 2001

Share article


Imprima English

Question
Dear OncoLink "Ask the Experts,"
If a woman is diagnosed with cervical dysplasia, does that mean she also has a HPV (Human Papilloma virus) infection? Or are those two things separate from one another?  
Thank you for your time.
D.H.


Answer
John Han-Chih Chang, MD and Kenneth Blank, MD, OncoLink Editorial Assistants, respond:

Dear D.H.,
Thank you for your interest and question.

Dysplasia means abnormality in cellular growth and development, and it is often used to refer to the morphologic alterations that characterize intraepithelial neoplasia (in the cervix, it is termed CIN). Abnormal nuclear shape and function within a cell, along with aberrant maturation, yields this microscopic diagnosis. In cervical cancer, CIN is considered a precursor to invasive cancer. The progression rate of low grade CIN to in-situ or noninvasive cancer is reported to be around 15% - 20%. The time to progression can be anywhere from 1 - 7 years depending on the grade of the CIN. CIN can remain dormant and even regress spontaneously without treatment in some patients. Causes of CIN are various, but they mainly are the result of some type of irritative agent of the epithelium. HPV is such an agent.

HPV or human papilloma virus is a sexually transmitted disease of the anogenital tract. It is the cause of anal or genital warts. It has a high propensity to cause CIN in women. Not all HPV infections cause CIN, though.

Thus, cervical dysplasia or CIN can be the result of HPV, but not all CIN is HPV-related and not all HPV infections cause CIN.

Imprima English
News
Hormonal Contraceptive Link to HPV, Cervical Cancer Examined

Oct 23, 2014 - Women using hormonal contraception who tested positive for the human papillomavirus are not at increased risk of developing cervical cancer, according to a study published in the May issue of the American Journal of Obstetrics & Gynecology. However, use of depot-medroxyprogesterone acetate (DMPA) is linked with higher risk of oncogenic HPV infection.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información